Business Description
Hanmi Science Co Ltd
NAICS : 325412
SIC : 2834
ISIN : KR7008930000
Compare
Compare
Traded in other countries / regions
008930.Korea IPO Date
1988-06-20Description
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.53 | |||||
| Interest Coverage | 3.98 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.35 | |||||
| Beneish M-Score | 5.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.4 | |||||
| 3-Year EBITDA Growth Rate | 59.6 | |||||
| 3-Year EPS without NRI Growth Rate | 73.4 | |||||
| 3-Year FCF Growth Rate | 32 | |||||
| 3-Year Book Growth Rate | 5.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.34 | |||||
| 9-Day RSI | 42.18 | |||||
| 14-Day RSI | 42.16 | |||||
| 6-1 Month Momentum % | 7.02 | |||||
| 12-1 Month Momentum % | -12.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.67 | |||||
| Quick Ratio | 0.42 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 30.53 | |||||
| Days Sales Outstanding | 28.15 | |||||
| Days Payable | 17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.03 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| 3-Year Dividend Growth Rate | 2 | |||||
| Forward Dividend Yield % | 1.03 | |||||
| 5-Year Yield-on-Cost % | 1.13 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 0.26 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.87 | |||||
| Operating Margin % | 3.45 | |||||
| Net Margin % | 8.18 | |||||
| FCF Margin % | 2.64 | |||||
| ROE % | 12.94 | |||||
| ROA % | 8.48 | |||||
| ROIC % | 2.92 | |||||
| ROC (Joel Greenblatt) % | 98.27 | |||||
| ROCE % | 15.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.02 | |||||
| PE Ratio without NRI | 18.69 | |||||
| Price-to-Owner-Earnings | 15.87 | |||||
| PEG Ratio | 0.48 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 2.37 | |||||
| Price-to-Tangible-Book | 2.57 | |||||
| Price-to-Free-Cash-Flow | 58.82 | |||||
| Price-to-Operating-Cash-Flow | 47.09 | |||||
| EV-to-EBIT | 16.22 | |||||
| EV-to-EBITDA | 15.2 | |||||
| EV-to-Revenue | 1.67 | |||||
| EV-to-FCF | 63.05 | |||||
| Price-to-Projected-FCF | 2.31 | |||||
| Price-to-DCF (Earnings Based) | 0.76 | |||||
| Price-to-DCF (FCF Based) | 1.71 | |||||
| Price-to-Median-PS-Value | 0.34 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.75 | |||||
| Price-to-Graham-Number | 1.46 | |||||
| Earnings Yield (Greenblatt) % | 6.16 | |||||
| FCF Yield % | 1.71 | |||||
| Forward Rate of Return (Yacktman) % | 20.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hanmi Science Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,283,652.146 | ||
| EPS (TTM) (â‚©) | 1549 | ||
| Beta | 0.77 | ||
| Volatility % | 64.67 | ||
| 14-Day RSI | 42.16 | ||
| 14-Day ATR (â‚©) | 1396.037829 | ||
| 20-Day SMA (â‚©) | 30452.5 | ||
| 12-1 Month Momentum % | -12.29 | ||
| 52-Week Range (â‚©) | 25750 - 56200 | ||
| Shares Outstanding (Mil) | 67.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hanmi Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hanmi Science Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hanmi Science Co Ltd Frequently Asked Questions
What is Hanmi Science Co Ltd(XKRX:008930)'s stock price today?
The current price of XKRX:008930 is â‚©29450.00. The 52 week high of XKRX:008930 is â‚©56200.00 and 52 week low is â‚©25750.00.
When is next earnings date of Hanmi Science Co Ltd(XKRX:008930)?
The next earnings date of Hanmi Science Co Ltd(XKRX:008930) is .
Does Hanmi Science Co Ltd(XKRX:008930) pay dividends? If so, how much?
The Dividend Yield %  of Hanmi Science Co Ltd(XKRX:008930) is 1.03% (As of Today), Highest Dividend Payout Ratio of Hanmi Science Co Ltd(XKRX:008930) was 0.66. The lowest was 0.12. And the median was 0.36. The  Forward Dividend Yield % of Hanmi Science Co Ltd(XKRX:008930) is 1.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers